Actinium Pharmaceuticals Inc (ATNM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -24,688 | -10,774 | -8,361 | -3,445 | 2 |
| Depreciation Amortization | 38 | 2 | 1,029 | 165 | N/A |
| Other Working Capital | 1,814 | -362 | 582 | 602 | 6 |
| Other Operating Activity | 8,487 | 4,841 | 1,539 | 2,159 | 0 |
| Operating Cash Flow | $-14,349 | $-6,292 | $-5,213 | $-518 | $8 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -152 | -17 | -2 | N/A | N/A |
| Other Investing Activity | -35 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-186 | $-17 | $-2 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 646 | 14 |
| Debt Repayment | -162 | -140 | N/A | N/A | -24 |
| Common Stock Issued | 15,711 | 2,896 | 5,130 | 5,379 | N/A |
| Other Financing Activity | 160 | 3,467 | 0 | 0 | 0 |
| Financing Cash Flow | $15,709 | $6,224 | $5,130 | $6,025 | $-10 |
| Beginning Cash Position | 5,533 | 5,619 | 5,704 | 196 | 2 |
| End Cash Position | 6,707 | 5,533 | 5,619 | 5,704 | 0 |
| Net Cash Flow | $1,173 | $-85 | $-85 | $5,508 | $-2 |
| Free Cash Flow | |||||
| Operating Cash Flow | -14,349 | -6,292 | -5,213 | -518 | 8 |
| Capital Expenditure | -152 | -17 | -2 | N/A | N/A |
| Free Cash Flow | -14,501 | -6,309 | -5,215 | -518 | 8 |